Core Viewpoint - The Financial Regulatory Administration has issued guidelines to promote the high-quality development of health insurance, emphasizing the need for deep reforms, enhanced sustainability, and improved regulatory frameworks to support the Healthy China strategy [1] Group 1: Reform of Health Insurance - The guidelines specify reform requirements for key health insurance products, including commercial medical insurance, long-term care insurance, income loss insurance due to disability, and disease insurance [2] - As of the end of August, the original insurance premium income from health insurance in life insurance companies reached 578.4 billion, accounting for 16.16% of total premium income, while property insurance companies reported 181.5 billion, making up 14.88% of their total [2] Group 2: Product System and Coverage - The guidelines propose a comprehensive, multi-tiered commercial medical insurance product system, encouraging the inclusion of new medical technologies, drugs, and devices in insurance coverage [3] - Long-term medical insurance should adjust pricing based on risk categories and improve the matching of premium rates with underwriting risks [3] - The guidelines support the development of personal account-based long-term medical insurance and the expansion of coverage for income loss insurance due to disability [3] Group 3: Sustainable Development and Professional Capacity - The guidelines emphasize enhancing the sustainable development capabilities of health insurance companies through improved professional capacity, digital application levels, and core competitiveness [5] - Issues such as product homogeneity and insufficient operational capabilities in the health insurance sector have been identified as constraints on service improvement [5] Group 4: Regulatory Enhancements - The guidelines call for strengthened health insurance regulation, including monitoring and addressing illegal activities, and ensuring consumer protection [6] - Future efforts will focus on creating a favorable policy environment for health insurance development and expediting the introduction of supporting business details for floating income health insurance [6]

Core Viewpoint - The article discusses the release of the "Guiding Opinions on Promoting High-Quality Development of Health Insurance" by the Financial Regulatory Bureau, which outlines 15 measures aimed at enhancing the regulation and sustainable development of health insurance in China, aligning with the Healthy China strategy [2]. Group 1: Deepening Health Insurance Reform - The Opinions propose specific reform requirements for major health insurance types, including commercial medical insurance, long-term care insurance, disability income loss insurance, and disease insurance [4]. - As of the end of August, the original insurance premium income for health insurance from life insurance companies was 578.4 billion yuan, accounting for 16.16% of total premium income, while property insurance companies reported 181.5 billion yuan, making up 14.88% of their total [4]. Group 2: Product System and Service Enhancement - The Opinions aim to establish a comprehensive, multi-tiered commercial medical insurance product system, incorporating new medical technologies, drugs, and devices into coverage [5]. - It encourages long-term medical insurance to price according to risk categories and improve the matching of premium rates with underwriting risks [5]. - The document supports the development of personal account-style long-term medical insurance and the expansion of coverage for disability income loss insurance [5]. Group 3: Sustainable Development and Professional Capacity - The Opinions emphasize enhancing the sustainable development capacity of health insurance companies through professional capability building and digital application improvements [8]. - It identifies issues such as product homogeneity and insufficient industry operational capacity that hinder service quality [8]. - The document calls for strengthening the responsibilities of insurance companies and improving actuarial management mechanisms [8]. Group 4: Regulatory Strengthening - The Opinions stress the importance of regulatory oversight to maintain market order and address illegal activities, including financial misconduct and misleading sales practices [11]. - The Financial Regulatory Bureau plans to enhance communication with other departments to create a favorable policy environment for health insurance development [11]. - It also aims to expedite the research and implementation of supporting business details for floating income health insurance [11].

Core Viewpoint - The recent guidelines issued by the Financial Regulatory Bureau aim to promote the high-quality development of health insurance in China, addressing existing challenges and enhancing the sustainability of health insurance services to support the Healthy China strategy [1][2]. Group 1: Expansion of Health Insurance Products - The guidelines encourage the development of commercial medical insurance and the expansion of health insurance product forms and functions, including the incorporation of new medical technologies, drugs, and devices into insurance coverage [2][3]. - There is a focus on establishing a comprehensive, multi-tiered commercial medical insurance product system, which will enhance the payment capabilities for new medical products through innovative payment methods [2][3]. Group 2: Long-term Medical Insurance Development - The guidelines support the development of long-term medical insurance by encouraging pricing based on risk categories and improving the matching of insurance rates with underwriting risks [3][4]. - The introduction of personal account-based long-term medical insurance is a notable aspect, allowing funds to cover out-of-pocket medical expenses and health management services [4]. Group 3: Integration of Health Insurance and Health Management - The guidelines propose a new health service guarantee system that integrates prevention, management, and protection, promoting the provision of medical, rehabilitation, and nursing services as part of health insurance [5][6]. - Insurance companies are encouraged to establish health management subsidiaries to enhance their service capabilities and better meet the health management needs of the public [6]. Group 4: Support for Well-rated Insurance Companies - The guidelines support well-rated insurance companies in launching new business initiatives, including dividend-type long-term health insurance and trial programs for increasing the cost-sharing ratio of health management in net premiums [7]. - This initiative aims to combine the floating income mechanism with public health needs, enhancing the profitability of insurance companies while benefiting consumers [7].

Core Viewpoint - The Financial Regulatory Bureau has issued guidelines to promote the high-quality development of health insurance, emphasizing its importance in providing financial protection against health-related losses and its role in the social security system [1] Group 1: Importance of Health Insurance - Health insurance is crucial for protecting individuals from financial losses due to health issues or medical actions, serving as an essential component of the social security network [1] - The demand for health insurance is increasing as economic and social development progresses alongside the Healthy China strategy [1] Group 2: Current Challenges - Despite rapid growth, the health insurance sector faces challenges such as a lack of product diversity, insufficient industry operational capabilities, weak foundations, underdeveloped professional institutions, and inadequate collaboration with the medical and pharmaceutical sectors [1] Group 3: Regulatory Response - In September 2024, the State Council issued opinions to enhance regulatory measures and prevent risks in the insurance industry, specifically calling for improved service levels in health insurance and support for the development of floating income insurance [1] - The Financial Regulatory Bureau has formulated guidelines to optimize existing policies, address bottlenecks, and clarify the future direction and development priorities of health insurance [1]

Core Viewpoint - The Financial Regulatory Administration has issued guidelines to promote the high-quality development of health insurance, emphasizing the need for effective implementation of policies and regulations [1] Group 1: Regulatory Measures - The guidelines stress the importance of strengthening regulatory coordination to ensure effective policy implementation [1] - Insurance companies are encouraged to optimize their health insurance performance management and improve their assessment and evaluation systems [1] Group 2: Customer Service Improvement - There is a focus on urging insurance companies to enhance their complaint management processes and increase the efficiency of complaint resolution [1] - The guidelines advocate for deeper collaboration between the headquarters and branches of insurance companies to improve sales, underwriting, and claims services in health insurance [1]

Core Viewpoint - The Financial Regulatory Administration has issued guidelines to promote the high-quality development of health insurance, focusing on innovative strategies and business models tailored to health insurance characteristics [1] Group 1: Development Strategies - The guidelines encourage the exploration of development strategies and business models that align with the unique characteristics of health insurance [1] - Emphasis is placed on deepening health management and integrating medical care with health and wellness services [1] Group 2: Support for Health Insurance Companies - Health insurance companies with good regulatory ratings will be supported in pilot programs to increase the cost-sharing ratio of health management in the net premium of health insurance products [1] - There is a trial initiative for the combined sale of health insurance and life insurance to better meet consumers' comprehensive protection needs [1]

Core Viewpoint - The article discusses the issuance of the "Guiding Opinions on Promoting High-Quality Development of Health Insurance" by the Financial Regulatory Bureau, emphasizing the need to enhance the health insurance sector's service and guarantee levels in response to increasing health protection demands and the aging population [1][12]. Summary by Sections 1. Increasing Demand for Health Insurance - The demand for health insurance is rising due to an aging population and increasing life expectancy, with the average life expectancy in China reaching 79 years [5]. - There is a growing need for commercial health insurance products, particularly for quick settlement of medical expenses and coverage of more medications not included in basic medical insurance [7][8]. 2. Breaking Through Bottlenecks - The health insurance sector has seen rapid growth since 2014, with commercial health insurance premium income expected to reach 977.3 billion by the end of 2024, more than six times the amount a decade ago, with a compound annual growth rate of approximately 20% [11]. - Despite this growth, challenges such as product homogeneity and insufficient operational capabilities are emerging, which hinder service improvement [11][12]. 3. Deepening Health Insurance Reform - The opinions outline a focus on enhancing the health management service system and promoting collaboration between health insurance and the healthcare industry [15][22]. - Specific areas of development include commercial medical insurance, long-term care insurance, and disability income loss insurance, with a push for integrating new medical technologies and drugs into insurance coverage [16][20]. 4. Enhancing Sustainable Development Capabilities - The article emphasizes the need for insurance companies to strengthen their responsibilities and improve actuarial management, as well as to enhance the professional talent pool in health insurance [24][25]. - It also highlights the importance of digital transformation and the use of big data and AI to improve operational efficiency and customer satisfaction [25]. 5. Strengthening Health Insurance Regulation - The regulatory framework will be improved to ensure compliance and fair pricing in health insurance products, with a focus on enhancing the overall market order [27][28]. - Measures will be taken to combat malpractice and protect consumer rights, ensuring a more transparent and efficient health insurance market [28]. 6. Optimizing the Health Insurance Development Environment - The article calls for the establishment of standardized health insurance clauses and evaluation systems to improve service quality and consumer understanding [31][32]. - It also encourages collaboration between various stakeholders to promote the development of group health insurance and improve public awareness of health insurance [32]. 7. Future Arrangements - The Financial Regulatory Bureau plans to create a favorable policy environment for health insurance development and to enhance product offerings to meet public demand for high-quality health protection [35].

《意见》提到，稳步发展疾病保险。结合疾病谱变化和医疗技术发展情况，及时修订疾病保险的疾病定 义。定期开展疾病发生率检视，适时更新人身保险业重大疾病经验发生率表。支持监管评级良好的保险 公司开展分红型长期健康保险业务。 北京商报讯（记者 李秀梅）9月30日，金融监管总局印发了《关于推动健康保险高质量发展的指导意 见》（以下简称《意见》）。 ...

Core Viewpoint - The Financial Regulatory Administration has issued guidelines to promote the high-quality development of health insurance, focusing on improving service efficiency and management in critical illness and long-term care insurance [1] Group 1: Health Insurance Development - The guidelines support insurance companies in enhancing critical illness insurance services and operational efficiency [1] - There is an emphasis on providing refined and standardized management services for long-term care insurance [1] Group 2: Management and Compliance - The guidelines call for the standardization of entrusted management contracts, leveraging the professional advantages of insurance companies [1] - There is a focus on comprehensive services including health protection scheme design, consulting, health management, medical service investigation, and payment auditing [1] - The guidelines stress the importance of compliance and fairness in the design of entrusted management business plans and fund payments [1]

Core Viewpoint - The Financial Regulatory Administration has released guidelines to promote the high-quality development of health insurance, outlining the overall development strategy and phased goals for the sector, aiming to enhance sustainable development capabilities and better meet public health insurance needs [1][2]. Group 1: Development Strategy - The guidelines emphasize the need to deepen health insurance reforms and enhance the regulatory framework to optimize the development environment for health insurance [1]. - Health insurance is identified as a crucial component of the social security network, linking the insurance industry with healthcare and impacting national and public welfare [1]. Group 2: Challenges and Issues - Despite rapid growth, the health insurance sector faces challenges such as a lack of product diversity, insufficient operational capabilities, weak foundations, underdeveloped specialized institutions, and inadequate collaboration with the medical and pharmaceutical sectors [1][2]. - These issues are seen as constraints on improving service and protection levels within the industry [1]. Group 3: Focus Areas for Development - The guidelines outline specific focus areas for four main types of health insurance: commercial medical insurance, commercial long-term care insurance, disability income loss insurance, and disease insurance [1]. - There is a plan to broaden product forms and functions, supporting the development of floating income health insurance and establishing a new health service protection system [1]. Group 4: Industry Foundation and Innovation - The guidelines aim to strengthen the industry's foundation by enhancing the professional capabilities of insurance companies and accelerating digital transformation [2]. - There is a push for policy support for health insurance companies to explore specialized operations and promote collaboration within the health industry, particularly in facilitating flexible and effective payments for innovative drugs and medical devices [2].